Healthcare -
Medical - Devices - NASDAQ - US
$ 1.01
2.02 %
$ 55.4 M
Market Cap
-2.81
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
50.08%
EBIT
Estimate
--40.84%
Net Income
Estimate
39.06%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cytosorbents Corporation
CTSO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart CTSO
EBIT FORECAST
EBIT Forecast Chart CTSO
NET INCOME FORECAST
Net Income Chart CTSO